Skip to content

Medpace Holdings, Inc. MEDP Change in receivables

Change in receivables at other companies

IQVIA logo
IQVIAIQV
-$15M+67.0%

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s change in receivables?
Medpace Holdings, Inc. (MEDP) reported change in receivables of -$7.82M in Q1 2026.
How has Medpace Holdings, Inc.'s change in receivables changed year-over-year?
Medpace Holdings, Inc.'s change in receivables decreased by 478.1% year-over-year, from $2.07M to -$7.82M.
What is the long-term trend for Medpace Holdings, Inc.'s change in receivables?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s change in receivables has grown at a 45.1% compound annual growth rate (CAGR), from $25.05M to $111.08M.
What does change in receivables mean?
The difference in money owed to the company by clients between two periods.
How do you interpret change in receivables?
An increase in receivables consumes cash, potentially signaling slower collection cycles or aggressive revenue recognition.
How does change in receivables compare across companies?
CROs typically have specific billing milestones; peers should show similar Days Sales Outstanding (DSO) trends.